stockportfolio.pro
PTC Therapeutics, Inc. EPS (Earnings per Share) 2011–2025
PTC Therapeutics, Inc. (PTCT) annual earnings per share by fiscal year, computed from SEC filings. Compound growth +3.9%/yr over 14 years.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $7.78 | +264.5% |
| FY 2024 | $-4.73 | +43.5% |
| FY 2023 | $-8.37 | -7.4% |
| FY 2022 | $-7.79 | -4.8% |
| FY 2021 | $-7.43 | -11.9% |
| FY 2020 | $-6.64 | -55.5% |
| FY 2019 | $-4.27 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
| FY 2015 | $0.00 | +100.0% |
| FY 2014 | $-2.97 | +42.7% |
| FY 2013 | $-5.18 | -112.2% |
| FY 2012 | $42.50 | +834.1% |
| FY 2011 | $4.55 | — |
Source: PTC Therapeutics, Inc. SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for PTC Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePTC Therapeutics, Inc. — frequently asked questions
What is PTC Therapeutics, Inc.'s earnings per share?
PTC Therapeutics, Inc. (PTCT) reported earnings per share of $7.78 for fiscal year 2025, per its SEC filings.
How has PTC Therapeutics, Inc.'s earnings per share changed over time?
Between fiscal 2011 and 2025, PTCT's earnings per share grew at roughly 3.9% per year (compound annual rate), from $4.55 to $7.78.
Where does this data come from?
Figures are computed from PTC Therapeutics, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.